Find out how an asset management firm leveraged insights gained from physicians sourced by techspert.io's AI search technology to make a better-informed investment decision.
A global financial services firm considering investing in a drug for septic shock asked techspert.io to support them with their due diligence.
They needed us to facilitate tele-depth interviews (12 participants) and quantitative online surveys (50 respondents) with US-based physicians in intensive care units, familiar with the above drug and experienced in treating septic shock.
Unlike other vendors who rely on static panels and closed-loop networks, our AI search technology rapidly finds experts based on specific project requirements with pinpoint precision.
It sifts through and analyzes billions of online data points worldwide, 24 hours a day, to produce accurate, comprehensive expert profiles at a much higher volume, speed, and accuracy than traditional human search methods.
This ensures that we identify experts that other vendors can’t and that we connect our customers with the experts of today, not yesterday.
Powered by advanced machine learning techniques, our AI identified the precise intensivists the customer needed for their due diligence, ensuring they got the domain-specific insights they sought.
Following the 50 survey responses and 12 tele-depth interviews, the customer swiftly developed a better understanding of physicians’ perception and uptake of the drug, and the treatment paradigm and potential shift in the clinical management of septic shock patients.
Therefore, enabling them to make a better-informed decision on their investment.
Some of the physicians the customer engaged with were:
A Critical Care Anesthesiologist who's co/authored 157 academic papers on the topic of sepsis and septic shock.
A Pediatric Intensive Care Specialist who's been heavily involved in four clinical trials in the space, one of which is on septic shock.
|A Professor of Anesthesiology and Medicine who runs a leading research lab that aims to define new methods for the treatment of sepsis.|